Zacks Investment Management Bio Techne Corp Transaction History

Zacks Investment Management

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$444.87 - $538.88 $1.12 Million - $1.36 Million	-2,522 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$387.35 - $450.26 $976,896 - $1.14 Million	2,522 New	2,522 $1.14 Million
Q3 2019 Nov 14, 2019	SELL	$183.56 - $216.72 $1.34 Million - $1.58 Million	-7,313 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$188.72 - $215.43 $1.38 Million - $1.58 Million	7,313 New	7,313 $1.53 Million

619

156M

161K

12.7K

Ticker TECH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,222,600
Market Cap $2.4B
Description
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...

Get notified when there are updates to the investment portfolio of Zacks Investment Management, based on Form 13F filings with the SEC.

Stay updated on Zacks Investment Management with notifications on news.